about
Frequency of HPA-15a and HPA-15b (Gov a/b) human platelet alloantigens in the Croatian population.ABO blood groups and genetic risk factors for thrombosis in Croatian population.Management of complaints in blood establishments: thirteen years of experience at the Croatian Institute of Transfusion Medicine.A Case of Neonatal Neutropenia Due to Anti-Fc Gamma Receptor IIIb Isoantibodies Treated with Recombinant Human Granulocyte Colony Stimulating Factor.Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD.Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.Hypervariable region 1 of hepatitis C virus genome and response to interferon therapy.Evaluation of ABO blood groups as a risk factor for myocardial infarction.Three-Year Experience in NAT Screening of Blood Donors for Transfusion Transmitted Viruses in Croatia.Detection of three blood donors with multiple myeloma by routine viral individual-donor nucleic acid testing screening.Combined cell index in assessing blood donor iron stores.ABO blood groups and psychiatric disorders: a Croatian study.Distribution of hepatitis C virus genotypes and subtypes in Croatia: 2008-2015Mapping of mhc class I and class II regions to different linkage groups in the zebrafish, Danio rerioDistribution of weak D types in the Croatian populationWarm red blood cell autoantibodies and clinical diagnoses in patients with or without autoimmune hemolysisThe Role of Pai-1 Gene 4g/5g Polymorphism and Diagnostic Value of Biomarkers in Allergic and Non-Allergic Asthma PhenotypeAnti-HBc prevalence among Croatian blood donors in a 14-year period (2004-2017): Assessment of trends, risks and need for implementing routine testing
P50
Q33369357-25BDFAF4-8109-48AD-8520-186AD15ECB0EQ33573170-3AFC3E1B-E03D-4001-9881-787E8FB80E85Q36159963-33D55DCB-E3CA-4490-8A1F-00E1BB8C62AAQ37325863-C45B9784-6B6E-4FA4-9545-BCE5056D3818Q37508079-5D2D3D9F-F9F1-4E67-A1EA-CB4976FB397AQ38699049-D17AF11E-48DA-419A-AF5A-68AF539529E3Q38930378-52E3B35E-6A99-46B0-9D83-459A000F17C4Q43001179-630EEB4E-49A6-4BAD-A24D-6D4400FF66B0Q43066477-09D45062-46EC-47F9-9AE8-C76936150518Q47552167-7311D050-E736-4AEF-BF23-4FE8C660DFE6Q47589904-D1B5B1FC-66AC-4E1C-84F2-BC52CCCD7322Q47984528-3F94E5FB-43B6-49DA-9CD8-C3D613D52E5AQ54095646-A6942600-D268-4327-8C84-3604BF1B0601Q59351246-E232C3F1-5547-492A-979C-20A1EF7931FAQ73363119-23548598-0A83-4E2B-A1C6-D0EEBB49F28AQ83303406-70C3DD66-C757-4B1A-890E-157B204D9772Q91215631-3AB73132-6783-4413-9827-3920CF133F67Q91752960-CC0FFFD5-98C6-4765-A8CC-DF79210BEEE6Q92462643-68F26DB4-092D-45F8-99F8-B15A7A4ECB84
P50
description
researcher ORCID ID = 0000-0002-9449-3154
@en
wetenschapper
@nl
name
Jasna Bingulac-Popovic
@ast
Jasna Bingulac-Popovic
@en
Jasna Bingulac-Popovic
@es
Jasna Bingulac-Popovic
@nl
type
label
Jasna Bingulac-Popovic
@ast
Jasna Bingulac-Popovic
@en
Jasna Bingulac-Popovic
@es
Jasna Bingulac-Popovic
@nl
prefLabel
Jasna Bingulac-Popovic
@ast
Jasna Bingulac-Popovic
@en
Jasna Bingulac-Popovic
@es
Jasna Bingulac-Popovic
@nl
P214
P106
P1153
6507801671
P214
P31
P496
0000-0002-9449-3154
P7859
viaf-305487537